Connect with us

coronavirus

UK to trial use of #COVID-19 survivors' blood plasma for treatment

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The United Kingdom is preparing to collect the blood from COVID-19 survivors to investigate if convalescent plasma transfusions could improve an infected patient’s speed of recovery and chances of survival, writes Guy Faulconbridge.

“NHS Blood and Transplant is preparing to collect COVID-19 convalescent plasma from people who have recovered from this illness,” a spokeswoman said. “We envisage that this will be initially used in trials as a possible treatment for COVID-19.”

“If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a COVID-19 patient’s speed of recovery and chances of survival,” the blood service said.

“We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible.”

People who have recovered from COVID-19 can register with the NHS if they are interested in donating plasma but they should not just turn up at blood donation centres.

Share this article:

Share this:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

Trending